KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Biomarin Pharmaceutical (BMRN) Shares Outstanding (2016 - 2022)

Historic Shares Outstanding for Biomarin Pharmaceutical (BMRN) over the last 14 years, with Q2 2022 value amounting to $185.5 million.

  • Biomarin Pharmaceutical's Shares Outstanding rose 116.24% to $185.5 million in Q2 2022 from the same period last year, while for Jun 2022 it was $185.5 million, marking a year-over-year increase of 116.24%. This contributed to the annual value of $183.9 million for FY2021, which is 119.51% up from last year.
  • According to the latest figures from Q2 2022, Biomarin Pharmaceutical's Shares Outstanding is $185.5 million, which was up 116.24% from $184.9 million recorded in Q1 2022.
  • In the past 5 years, Biomarin Pharmaceutical's Shares Outstanding ranged from a high of $185.5 million in Q2 2022 and a low of $176.7 million during Q1 2018
  • In the last 5 years, Biomarin Pharmaceutical's Shares Outstanding had a median value of $181.0 million in 2020 and averaged $181.0 million.
  • Its Shares Outstanding has fluctuated over the past 5 years, first skyrocketed by 193.24% in 2018, then surged by 88.92% in 2019.
  • Quarter analysis of 5 years shows Biomarin Pharmaceutical's Shares Outstanding stood at $178.3 million in 2018, then rose by 0.89% to $179.8 million in 2019, then rose by 1.06% to $181.7 million in 2020, then increased by 1.2% to $183.9 million in 2021, then increased by 0.84% to $185.5 million in 2022.
  • Its Shares Outstanding stands at $185.5 million for Q2 2022, versus $184.9 million for Q1 2022 and $183.9 million for Q4 2021.